These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10710573)

  • 1. Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population.
    Wallis EJ; Ramsay LE; Ul Haq I; Ghahramani P; Jackson PR; Rowland-Yeo K; Yeo WW
    BMJ; 2000 Mar; 320(7236):671-6. PubMed ID: 10710573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary and cardiovascular risk estimation in uncomplicated mild hypertension. A comparison of risk assessment methods.
    Yikona JI; Wallis EJ; Ramsay LE; Jackson PR
    J Hypertens; 2002 Nov; 20(11):2173-82. PubMed ID: 12409955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of the new Sheffield table and the modified joint British societies coronary risk prediction chart against a laboratory based risk score calculation.
    Rabindranath KS; Anderson NR; Gama R; Holland MR
    Postgrad Med J; 2002 May; 78(919):269-72. PubMed ID: 12151567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of coronary risk for primary prevention of coronary heart disease: a comparison of methods.
    Haq IU; Ramsay LE; Jackson PR; Wallis EJ
    QJM; 1999 Jul; 92(7):379-85. PubMed ID: 10627887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is coronary risk an accurate surrogate for cardiovascular risk for treatment decisions in mild hypertension? A population validation.
    Wallis EJ; Ramsay LE; Haq IU; Ghahramani P; Jackson PR
    J Hypertens; 2001 Apr; 19(4):691-6. PubMed ID: 11330871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identification of subjects at high risk of coronary disease in a working population using a prediction model].
    Laurier D; Chau NP
    Arch Mal Coeur Vaiss; 1995 Nov; 88(11):1569-75. PubMed ID: 8745990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.
    Kones R
    Drug Des Devel Ther; 2011; 5():325-80. PubMed ID: 21792295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting coronary risk in the general population--is it necessary to measure high-density lipoprotein cholesterol?
    Wilson S; Johnston A; Robson J; Poulter NR; Collier DJ; Feder GS; Caulfield MJ
    J Cardiovasc Risk; 2003 Apr; 10(2):137-41. PubMed ID: 12668911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total cholesterol, low density lipoprotein cholesterol, and high density lipoprotein cholesterol and coronary heart disease in Scotland.
    Hargreaves AD; Logan RL; Thomson M; Elton RA; Oliver MF; Riemersma RA
    BMJ; 1991 Sep; 303(6804):678-81. PubMed ID: 1912914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population implications of lipid lowering for prevention of coronary heart disease: data from the 1995 Scottish health survey.
    Haq IU; Ramsay LE; Wallis EJ; Isles CG; Ritchie LD; Jackson PR
    Heart; 2001 Sep; 86(3):289-95. PubMed ID: 11514481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of serum lipid level change on 10-year coronary heart risk distribution estimated by means of seven different coronary risk scores during one-year treatment.
    Kojić NE; Derić M; Dejanović J
    Med Pregl; 2014; 67(7-8):208-15. PubMed ID: 25151760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of Non-Fasting Lipid Profile for the Assessment of Lipoprotein Coronary Risk.
    Fatima S; Ijaz A; Sharif TB; Khan DA; Siddique A
    J Coll Physicians Surg Pak; 2016 Dec; 26(12):954-957. PubMed ID: 28043305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of methods to identify individuals at increased risk of coronary disease from the general population.
    Wilson S; Johnston A; Robson J; Poulter N; Collier D; Feder G; Caulfield MJ
    BMJ; 2003 Jun; 326(7404):1436. PubMed ID: 12829557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative accuracy of cardiovascular risk prediction methods in patients with diabetes mellitus.
    Game FL; Bartlett WA; Bayly GR; Jones AF
    Diabetes Obes Metab; 2001 Aug; 3(4):279-86. PubMed ID: 11520308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.
    Vallejo-Vaz AJ; Robertson M; Catapano AL; Watts GF; Kastelein JJ; Packard CJ; Ford I; Ray KK
    Circulation; 2017 Nov; 136(20):1878-1891. PubMed ID: 28877913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study in primary care in patients without vascular disease comparing levels of coronary risk factors in those recommended for lipid-lowering drugs based on either absolute risk or absolute risk reduction.
    Ramachandran S; Croft P; Neary RH
    Prev Cardiol; 2003; 6(1):17-21. PubMed ID: 12624557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Lipid Thresholds for Screening Predict the Need for Pharmacotherapy.
    Zawacki A; Dodge A; Eickhoff J; Sun W; Marriott E; Ralphe JC; Peterson AL
    J Pediatr; 2018 Nov; 202():220-225.e2. PubMed ID: 30172432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex and time differences in the associations of non-high-density lipoprotein cholesterol versus other lipid and lipoprotein factors in the prediction of cardiovascular death (The Rancho Bernardo Study).
    von Mühlen D; Langer RD; Barrett-Connor E
    Am J Cardiol; 2003 Jun; 91(11):1311-5. PubMed ID: 12767422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol and coronary heart disease: predicting risks by levels and ratios.
    Kinosian B; Glick H; Garland G
    Ann Intern Med; 1994 Nov; 121(9):641-7. PubMed ID: 7944071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.